Sustained benefit of compression therapy for preventing recurrent leg cellulitis: extended follow-up of a randomised controlled trial
Compression therapy durably reduced recurrent leg cellulitis in adults with chronic leg swelling.
*Open-label randomized controlled trial with extended follow-up; Level 1b.
Citation
Webb E, Neeman T, Bowden FJ, Gaida J, Mumford V, Bissett B. eClinicalMedicine. 2026;98:104127. doi:10.1016/j.eclinm.2026.104127
Background
Recurrent leg cellulitis causes repeated illness, hospital use, and antibiotic exposure. Chronic leg swelling is a major modifiable risk factor, but swelling-focused prevention has been underused.
Patients
90 Australian adults with chronic leg swelling for at least 3 months and at least 2 cellulitis episodes in the same leg within 2 years. Exclusions included effective current compression use, contraindication to compression, end-of-life care, unstable illness, or specialist-managed chronic wounds.
Intervention
Cellulitis prevention education plus individualized fitted compression garments, worn during waking hours.
Control
Cellulitis prevention education alone; compression was later offered after early trial stopping for benefit.
Outcome
Primary: time to first recurrent cellulitis. Secondary: cellulitis-related hospital admission, leg volume, and quality of life.
Follow-up Period
Median 18 months.
Results
| Outcome | Compression | Control | Effect |
|---|---|---|---|
| Recurrent cellulitis (primary) | 9/45 (20%) | 21/45 (47%) | HR 0.23 (95% CI 0.10 to 0.52); NNT 4 |
| Hospitalization for recurrent cellulitis | 4/45 (9%) | 8/45 (18%) | HR 0.25 (95% CI 0.07 to 0.90); NNT 12 |
HR = hazard ratio; NNT = number needed to treat.
Analyses were by intention to treat. Adherence was high: 85% wore garments at least 4 days weekly. The control was education-only, not active compression. This was not a non-inferiority trial.
Limitations
Single-center, open-label trial stopped early for benefit. Crossover limited longer randomized comparison. Cellulitis diagnosis and adherence partly relied on participant report. Findings apply best to higher-risk adults with chronic leg swelling and recurrent leg cellulitis; benefit may be smaller in lower-risk patients.
Funding
Haddenham Healthcare provided garments; funders had no data role.
Clinical Application
Offer fitted compression therapy to patients with chronic leg swelling and recurrent leg cellulitis, alongside skin care and risk-factor management.
Journal Club
Discussion questions and an EBM quiz for this paper. How to run a journal club →
Discussion
Sign in to join the discussion.
No comments yet. Be the first to share your thoughts.